New approaches and targets in advanced colorectal cancer.
Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Teresa
T
Macarulla
Jaume
J
Capdevila
José
J
Perez-Garcia
Francisco Javier
FJ
Ramos
Maria Elena
ME
Elez
Ben
B
Markman
Manuel
M
Ruiz-Echarri
Josep
J
Tabernero
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D006801:Humans; D051058:Oncogene Protein v-akt / Q000037:antagonists & inhibitors; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011494:Protein Kinases / Q000378:metabolism; D051736:Proto-Oncogene Proteins c-mdm2 / Q000037:antagonists & inhibitors; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000037:antagonists & inhibitors; D017451:Receptors, Somatomedin / Q000037:antagonists & inhibitors; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000037:antagonists & inhibitors; D058570:TOR Serine-Threonine Kinases; D019061:src-Family Kinases / Q000037:antagonists & inhibitors
D000081082:Phosphoinositide-3 Kinase Inhibitors; D017451:Receptors, Somatomedin; D053221:TNF-Related Apoptosis-Inducing Ligand; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2; D011494:Protein Kinases; C546842:MTOR protein, human; D066246:ErbB Receptors; D019859:Proto-Oncogene Proteins c-met; D020796:Receptor, Platelet-Derived Growth Factor alpha; D040262:Receptors, Vascular Endothelial Growth Factor; D019061:src-Family Kinases; D051058:Oncogene Protein v-akt; D058570:TOR Serine-Threonine Kinases